多替阿巴拉米片服用方法

(Suimeikai) How to take: This product should be taken under the guidance of a physician with experience in HIV infection. Dosage Adults and Adolescents (Weighing at least 40 kg) For adults and adolescents, the recommended dose is one tablet once daily. Adults or adolescents whose body weight is less than 40 kg should not be given this product because this product is a fixed-dose tablet and the dose cannot be reduced. This product is a fixed-dose tablet and should not be used in patients who require dose adjustments. If one of the active ingredients needs to be discontinued or a dose adjustment is required, separate formulations of dolutegravir, abacavir, or lamivudine may be used. In these cases, physicians should refer to the respective product information for these medicines. Missed dose If the patient misses a dose of this product and there are more than 4 hours before the next dose, the patient should take this product as soon as possible. If the next dose is less than 4 hours away, patients should not take the missed dose and simply resume their usual dosing schedule. Patients with renal impairment and creatinine clearance less than 50mL/min are not recommended to take this product. Hepatic Impairment Abacavir is primarily metabolized by the liver.

This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China. Retail price 2880$/month. Produced by the Indian Emcure company (Inbec), it costs about $1,000. Trimax is a medicine containing three active ingredients, used to treat HIV infection in adults and children over 12 years of age weighing more than 40 kilograms. Trimax contains three ingredients: abacavir, lamivudine and dolutegravir. Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs); dolutegravir is an integrase inhibitor (INIs). Existing research shows that one year (48 weeks) after HIV infection treatment, 93% of HIV-infected patients turned negative.